RadNet announced that its subsidiary DeepHealth, a developer of artificial intelligence for mammography interpretation, has received FDA clearance of its mammography density assessment software, Saige-Density. Saige-Density is a breast density assessment tool that automatically generates an ACR BI-RADS breast density category, assisting radiologists in making accurate and consistent determinations using AI. The tool helps to reduce the subjectivity inherent in visual analysis.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on RDNT:
- RadNet’s Artificial Intelligence Subsidiary, DeepHealth, Announces FDA Clearance of its Third AI Mammography Product
- RadNet, Inc. to Present at the Sidoti & Company December 2022 Small-Cap Virtual Conference on Wednesday, December 7th
- RadNet’s Aidence, Google Health enter collaboration for lung cancer screening
- RadNet subsidiary, Google Health announce agreement to license AI research model
- RadNet, Inc. to Present at the BofA Securities 2022 Leveraged Finance Conference on November 29, 2022